Status:
UNKNOWN
Effectiveness of Shared Care Diabetes Management in Patients With Type 2 Diabetes
Lead Sponsor:
Beijing Chao Yang Hospital
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This is a prospective, randomization, parallel, controlled study to evaluate the effectiveness of Shared Care diabetes management. Patients with T2DM involved in the Shared Care model pay regularly qu...
Detailed Description
With population aging and increasing prevalence of obesity in China, the number of patients with diabetes mellitus, healthcare expenditure and mortality related to DM are forecast to grow substantiall...
Eligibility Criteria
Inclusion
- Patients diagnosed with T2DM
- Patients who have Informed and signed the consent form content
- Patients can be regularly followed (every 3 months) for at least 3 years
Exclusion
- Patients with important organ failure or other severe diseases including infection, mentally disorder, heart failure or disseminated intravascular coagulation
- Patients with active or inactive malignant tumour, expectation of life less than 1 year
- Patients with communication disorders, cannot communicate and/or cooperate
- Females that are regnant, breast-feeding female, or conception plan in the recent year
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04100278
Start Date
January 1 2020
End Date
December 31 2023
Last Update
September 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Chao-Yang Hospital, Capital Medical University
Beijing, Beijing Municipality, China